Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment
India | April 05, 2021 14:02 ISTDrug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19.